ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
Myeloma
ecancer
Isa-KRd in NDMM: Takeaways From the MIDAS & CONCEPT Studies
FEATURING
Philippe Moreau
- 7 views
- November 18, 2024
ecancer
Frailty Subanalysis of IMROZ: Isatuximab + RVD for Transplant-Ineligible NDMM Patients
FEATURING
Salomon Manier
- 10 views
- November 12, 2024
ecancer
Idecabtagene Vicleucel for R/R MM: Updated Results From the KarMMa Trial
FEATURING
Larry Anderson
- 60 views
- October 21, 2021
ecancer
Efficacy and Safety Data for Ciltacabtagene Autoleucel in Progressive Multiple Myeloma: CARTITUDE-2 Trial Updates
FEATURING
Adam D. Cohen
- 126 views
- October 21, 2021
ecancer
Melflufen and Dexamethasone vs. Pomalidomide and Dexamethasone in R/R MM: Results of the OCEAN Trial
FEATURING
Fredrik Schjesvold
- 50 views
- October 21, 2021
ecancer
EHA 2021 Highlights on KRd for Lenalidomide-Refractory MM
FEATURING
Claudio Cerchione
- 92 views
- September 2, 2021
- 1
ecancer
EHA 2021 Update on Carfilzomib Non-refractory MM: Surveying Efficacy Data of Once Weekly XKd
FEATURING
Cristina Gasparetto
- 66 views
- September 2, 2021
ecancer
EHA 2021 Update on D-Rd vs. Rd in Transplant-Ineligible Newly Diagnosed MM: MAIA Study
FEATURING
Thierry Facon
- 19 views
- September 2, 2021
